Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guiqin Sun
Observed names:
G P Sun,
G. Sun,
G.P. Sun
Institution:
Zhejiang Chinese Medical University
Observed institutions:
Zhejiang Chinese Medical University,
Fudan University,
Shandong Marine Resource and Environment Research Institute,
First Affiliated Hospital of Anhui Medical University
ORCID:
0000-0002-2819-6063
Observed ORCID:
0000-0002-2819-6063
OpenAlex ID:
A5038313576
Helicobacter pylori Infection Predicts Favorable Outcome in Patients with Gastric Cancer
2013
·
F. Wang
, G.P. Sun
, et al.
·
Current Oncology
·
39
PDF
[A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer].
2018
·
Z F Jiang
, F R Xu
, et al.
·
PubMed
·
10
Functional prediction of the potential NGLY1 mutations associated with rare disease CDG
2024
·
Shuying Yuan
, Yanwen Chen
, et al.
·
Heliyon
·
7
Characterization and Molecular Mechanism of Aminoglycoside-6-Adenyl Transferase Associated with Aminoglycoside Resistance from Elizabethkingia meningoseptica
2023
·
Shaoxing Zhang
, Yuxin Zhang
, et al.
·
Infection and Drug Resistance
·
7
PDF
A Natural Compound Containing a Disaccharide Structure of Glucose and Rhamnose Identified as Potential N-Glycanase 1 (NGLY1) Inhibitors
2023
·
Ruijie Liu
, Jingjing Gu
, et al.
·
Molecules
·
5
PDF
Identification and characterization of an α-1,3 mannosidase from Elizabethkingia meningoseptica and its potential attenuation impact on allergy associated with cross-reactive carbohydrate determinant
2023
·
Danfeng Shen
, Xinrong Lu
, et al.
·
Biochemical and Biophysical Research Communications
·
5
Nonlinear effects of meteorological factors on foodborne disease outbreaks in yantai from 2014 to 2024
2025
·
Youxia Chen
, Zhonghao Yuan
, et al.
·
Scientific Reports
·
3
PDF
Rare Infectious Diseases: Detection and Clinical Implications
2025
·
Xin Qian
, Yuxin Zhang
, et al.
·
iLABMED
·
3
PDF
104P Safety and efficacy of HLX04 versus reference bevacizumab in combination with XELOX or mFOLFOX6 as first-line treatment for metastatic colorectal cancer: A randomised, double-blind phase III study
2020
·
S. Qin
, J. Li
, et al.
·
Annals of Oncology
·
2
PDF
Recharacterization of EmAGA, a Potential Candidate for Novel ALL Therapeutics
2026
·
Qiange Lin
, Yuxin Zhang
, et al.
·
Biomolecules
Identification and characterization of a novel exo-(N-)glycanase activity of NGLY1 on ENGase-digested N-GlcNAc proteins in vitro
2025
·
Yilin Ye
, Xinrong Lu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
11
Citation count:
81
H-index:
5
I10-index:
2
Year
Topic
Type